[1]
|
王贵强, 段钟平, 王福生, 等. 慢性乙型肝炎防治指南(2019年版) [J]. 实用肝脏病杂志, 2020, 23(1): 9-32.
|
[2]
|
中国肝炎防治基金会, 中华医学会感染病学会分会, 中华医学会肝病学分会, 中国研究型医院 学会肝病专业委员会. 瞬时弹性成像技术诊断肝纤维化专家共识(2018年更新版) [J]. 中华肝脏病杂志, 2019, 27(3): 182-191.
|
[3]
|
Herrmann, E., De, Ledinghen, V., Cassinotto, C., et al. (2018) Assessment of Biopsy-Proven Liver Fibrosis by Two- Dimensional Shear Wave Elastography: An Individual Patient Data-Based Meta-Analysis. Hepatology, 67, 260-272.
https://doi.org/10.1002/hep.29179
|
[4]
|
Kamal, S.M., Turner, B., He, Q., et al. (2006) Progression of Fibrosis in Hepatitis C with and without Schistosomiasis: Correlation with Serum Markers of Fibrosis. Hepatology, 43, 771-779. https://doi.org/10.1002/hep.21117
|
[5]
|
Degos, F., Perez, P., Roche, B., et al. (2010) Diagnostic Accuracy of FibroScan and Comparison to Liver Fibrosis Biomarkers in Chronic Viral Hepatitis: A Multicenter Prospective Study (the FIBROSTIC Study). Journal of Hepatology, 53, 1013-1021. https://doi.org/10.1016/j.jhep.2010.05.035
|
[6]
|
Johansen, J.S., Moller, S., Price, P.A., et al. (1997) Plasma YKL-40: A New Potential Marker of Fibrosis in Patients with Alcoholic Cirrhosis? Scandinavian Journal of Gastroenterology, 32, 582-590.
https://doi.org/10.3109/00365529709025104
|
[7]
|
Libreros, S., Garcia-Areas, R. and Iragavarapu-Charyulu, V. (2013) CHI3L1 Plays a Role in Cancer through Enhanced Production of Pro-Inflammatory/Pro-Tumorigenic and Angiogenic Factors. Immunologic Research, 57, 99-105.
https://doi.org/10.1007/s12026-013-8459-y
|
[8]
|
Wang, L., Liu, T., Zhou, J., et al. (2018) Changes in Serum Chitinase 3-Like 1 Levels Correlate with Changes in Liver Fibrosis Measured by Two Established Quantitative Methods in Chronic Hepatitis B Patients Following Antiviral Therapy. Hepatology Research, 48, E283-E290. https://doi.org/10.1111/hepr.12982
|
[9]
|
Huang, H., Wu, T., Mao, J., et al. (2015) CHI3L1 Is a Liver-Enriched, Noninvasive Biomarker That Can Be Used to Stage and Diagnose Substantial Hepatic Fibrosis. OMICS, 19, 339-345. https://doi.org/10.1089/omi.2015.0037
|
[10]
|
Jiang, Z., Wang, S., Jin, J., et al. (2020) The Clinical Significance of Serum Chitinase 3-Like 1 in Hepatitis B-Related Chronic Liver Diseases. Journal of Clinical Laboratory Analysis, 34, e23200. https://doi.org/10.1002/jcla.23200
|
[11]
|
Kladney, R.D., Cui, X., Bulla, G.A., et al. (2002) Expression of GP73, a Resident Golgi Membrane Protein, in Viral and Nonviral Liver Disease. Hepatology, 35, 1431-1440. https://doi.org/10.1053/jhep.2002.32525
|
[12]
|
Iftikhar, R., kladney, R.D., Havlioglu, N., et al. (2004) Disease- and Cell-Specific Expression of GP73 in Human Liver Disease. American Journal of Gastroenterology, 99, 1087-1095.
|
[13]
|
Wei, H., Li, B., Zhang, R., et al. (2013) Serum GP73, a Marker for Evaluating Progression in Patients with Chronic HBV Infections. PLoS One, 8, e53862. https://doi.org/10.1371/journal.pone.0053862
|
[14]
|
Yao, M., Wang, L., You, H., et al. (2019) Serum GP73 Combined AST and GGT Reflects Moderate to Severe Liver Inflammation in Chronic Hepatitis B. Clinica Chimica Acta, 493, 92-97. https://doi.org/10.1016/j.cca.2019.02.019
|
[15]
|
Qian, X., Zheng, S., Wang, L., et al. (2019) Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries. Dis Markers, 2019, Article ID: 3862024. https://doi.org/10.1155/2019/3862024
|
[16]
|
Ajo-Franklin, J.B., Dou, S., Lindsey, N.J., et al. (2019) Distributed Acoustic Sensing Using Dark Fiber for Near-Surface Characterization and Broadband Seismic Event Detection. Scientific Reports, 9, Article No.: 1328.
https://doi.org/10.1038/s41598-018-36675-8
|
[17]
|
Queck, A., Bode, H., Uschner, F.E., et al. (2020) Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis. Frontiers in Immunology, 11, 354.
https://doi.org/10.3389/fimmu.2020.00354
|
[18]
|
Baeck, C., Wei, X., Bartneck, M., et al. (2014) Pharmacological Inhibition of the Chemokine C-C Motif Chemokine ligand 2 (Monocyte Chemoattractant Protein 1) Accelerates Liver Fibrosis Regression by Suppressing Ly-6C(+) Macrophage Infiltration in Mice. Hepatology, 59, 1060-1072. https://doi.org/10.1002/hep.26783
|
[19]
|
Ehling, J., Bartneck, M., Wei, X., et al. (2014) CCL2-Dependent Infiltrating Macrophages Promote Angiogenesis in Progressive Liver Fibrosis. Gut, 63, 1960-1971. https://doi.org/10.1136/gutjnl-2013-306294
|
[20]
|
Fan, Y., Wang, L. and Dou, X. (2018) Serum Monocyte Chemoattractant Protein-1 Predicts Liver Inflammation of Patients with Chronic Hepatitis B. Clinical Laboratory, 64, 841-846. https://doi.org/10.7754/Clin.Lab.2017.171218
|
[21]
|
Swiderska, M., Jaroszewicz, J., Parfieniuk-Kowerda, A., et al. (2017) Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease. Mediators Inflamm, 2017, Article ID: 3480234.
https://doi.org/10.1155/2017/3480234
|
[22]
|
Rosso, C., Caviglia, G.P., Abate, M.L., et al. (2016) Cytokeratin 18-Aspartate396 Apoptotic Fragment for Fibrosis Detection in Patients with Non-Alcoholic Fatty Liver Disease and Chronic Viral Hepatitis. Digestive and Liver Disease, 48, 55-61. https://doi.org/10.1016/j.dld.2015.09.008
|
[23]
|
Bae, C.B., Kim, S.S., Ahn, S.J., et al. (2013) Caspase-Cleaved Fragments of Cytokeratin-18 as a Marker of Inflammatory Activity in Chronic Hepatitis B Virus Infection. Journal of Clinical Virology, 64, 641-646.
https://doi.org/10.1016/j.jcv.2013.10.008
|
[24]
|
Li, Q., Huang, C., Xu, W., et al. (2019) A Simple Algorithm for Non-Invasive Diagnosis of Significant Liver Histological Changes in Patients with CHB and Normal or Mildly Elevated Alanine Transaminase Levels. Medicine (Baltimore), 98, e16429. https://doi.org/10.1097/MD.0000000000016429
|
[25]
|
Li, Q., Zhou, Y., Huang, C., et al. (2018) A Novel Diagnostic Algorithm to Predict Significant Liver Inflammation in Chronic Hepatitis B Virus Infection Patients with Detectable HBV DNA and Persistently Normal Alanine Transaminase. Scientific Reports, 8, Article No.: 15449. https://doi.org/10.1038/s41598-018-33412-z
|